GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the anthrax drug target, bacillus anthracis dihydrofolate reductase

Analyse Crystal structure of the anthrax drug target, bacillus anthracis dihydrofolate… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2QK8
Type
protein
Length
162 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dihydrofolate reductase
EC
1.5.1.3
UniProt
Q81R22
Ligands
MTX
Pockets
2 · best druggability 0.68

Structure

x-ray diffraction · 1 distinct chain · 19% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADihydrofolate reductase (EC 1.5.1.3)protein16219% helix, 30% strandQ81R22

Ligands and binding sites

  • MTX · Methotrexate · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13750.680.8145MTX
2560.400.8113empty

Compared structures

  • 2QK8 · Crystal structure of the anthrax drug target, Bacillus anthracis dihydrofolate reductase · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.